What are the contraindications to the progesterone-only oral contraceptive (mini‑pill)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Contraindications to Progesterone-Only Pills

Progesterone-only pills (POPs) have remarkably few absolute contraindications, with current breast cancer being the only condition classified as an unacceptable health risk for initiation. 1

Absolute Contraindication

  • Current breast cancer is the sole Category 4 (unacceptable health risk) contraindication to POPs 2
    • This represents only 0.57-2.67% of women seeking contraceptive services 2

Clinical Situations Requiring Caution or Alternative Approaches

Cardiovascular Disease with Multidisciplinary Consultation Required

Women with a personal history of arterial events (coronary heart disease or stroke) should first be offered non-hormonal methods, preferably a copper IUD. If poorly tolerated, POPs may only be considered after multidisciplinary consultation. 1

Antiphospholipid Antibody Syndrome - Specific Progestin Considerations

For women with positive antiphospholipid antibodies:

  • Strongly recommend POPs or levonorgestrel IUDs 3, 4
  • Do NOT recommend depot medroxyprogesterone acetate (DMPA) due to thrombogenicity concerns 3, 4
  • Insufficient data exists for the etonogestrel subdermal implant in this population 4

Systemic Lupus Erythematosus

  • POPs are appropriate for SLE patients with moderate or severe disease activity 3, 4
  • No unexpected increase in venous or arterial events was observed in SLE patients using progestin-only contraception 1

Key Clinical Advantages

POPs can be safely used in multiple situations where combined hormonal contraceptives are contraindicated:

  • Personal history of venous thromboembolism 1
  • Documented thrombophilia without clinical events 1
  • Family history of thromboembolic events in first-degree relative before age 60 1
  • Smokers over age 35 (any number of cigarettes) 1
  • Migraine with aura
  • Hypertension 5

Important Clinical Pearls

The overall prevalence of contraindications to POPs among reproductive-age women is remarkably low at 4.36% in the general population and only 2.29% among women specifically seeking contraceptive services. 2 This low contraindication rate supports the safety profile for potential over-the-counter access to POPs.

Unlike combined hormonal contraceptives, POPs do not increase myocardial infarction risk (RR 1.07,95% CI 0.62-1.83), making them suitable for women with cardiovascular risk factors. 1

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.